(Q37968642)

26 August 2017

title

Physicochemical and physiological considerations for efficient nose-to-brain targeting (English)

1 reference

26 August 2017

Shiv Bahadur

1

1 reference

26 August 2017

Kamla Pathak

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

16 December 2011

1 reference

Expert Opinion on Drug Delivery

26 August 2017

published in

1 reference

26 August 2017

volume

9

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

19-31

1 reference

Intranasal drug delivery: a novel approach

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Micellar nanocarriers: potential nose-to-brain delivery of zolmitriptan as novel migraine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Insulin gel as an alternate to parenteral insulin: formulation, preclinical, and clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Study on brain targeting of raltitrexed following intranasal administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Intranasal delivery of antiepileptic medications for treatment of seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Intranasal nanoemulsion based brain targeting drug delivery system of risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Strategy for effective brain drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Intranasal delivery: physicochemical and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Nasal drug delivery--possibilities, problems and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Direct transport of VEGF from the nasal cavity to brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Transport of drugs from the nasal cavity to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Gold nanoparticles: opportunities and challenges in nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

New strategies to deliver anticancer drugs to brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Nasal route and drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of zidovudine: influence of combination of hydrophilic and hydrophobic matrix formers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Nasal delivery of high molecular weight drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Intranasal insulin: from nose to brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability after nasal administration in the sheep model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

The nasal delivery of peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

The nose and paranasal sinuses physiology and anatomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Drug metabolism in the nasal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

The influence of drugs on nasal ciliary movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Intranasal delivery--modification of drug metabolism and brain disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

A new minimal-stress freely-moving rat model for preclinical studies on intranasal administration of CNS drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Nanoparticles for nasal vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Nanoparticles for direct nose-to-brain delivery of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

In vitro polarized transport of L-phenylalanine in human nasal epithelium and partial characterization of the amino acid transporters involved.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Drug targeting to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

Freeze-dried chitosan/pectin nasal inserts for antipsychotic drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.636801

10.1517/17425247.2012.636801

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference